查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2069216

寵物微生物組診斷市場預測—全球產品類型、檢體類型、動物種類、技術、應用、最終用戶和地區分析—2034年

Pet Microbiome Diagnostics Market Forecasts to 2034 - Global Analysis By Product (Testing Kits, Instruments and Software and Services), Sample Type, Animal Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

全球寵物微生物組診斷市場預計到 2026 年將達到 5 億美元，並在預測期內以 15.6% 的複合年成長率成長，到 2034 年達到 16 億美元。

寵物微生物組診斷是指利用先進的基因組學和分子診斷技術，分析和評估伴侶動物消化器官系統、皮膚、口腔及其他生物環境中微生物群落的組成。這些診斷方法可以評估有益和有害微生物的組成、多樣性和功能活性，並識別與健康狀況相關的失衡情況。寵物微生物組診斷有助於疾病檢測、最佳化營養管理、預防保健、制定個人化治療方案以及進行整體健康管理。

腸道健康科學進展

越來越多的科學證據表明，伴侶動物腸道微生物群的組成與消化器官系統、免疫、皮膚類和行為等各個方面的整體健康密切相關，這推動了臨床和消費者對腸道微生物群診斷的需求。同行評審的研究表明，特定的微生物特徵與發炎性腸道疾病、食物過敏和異位性皮膚炎等疾病之間存在相關性，這增強了獸醫對微生物群診斷效用的信心。益生菌和益生元產品的生產商正在委託進行微生物群診斷檢測，以支持其產品功效聲明並協助開發個人化推薦平台。

缺乏獸醫基準值

缺乏對健康伴侶動物（無論品種、年齡或地理位置）微生物組組成的有效檢驗範圍，嚴重限制了微生物組診斷結果的臨床解讀。由於缺乏標準化的參考資料資料庫，獸醫無法可靠地區分病理性腸道菌叢異常和正常的微生物波動，導致診斷可靠性降低，臨床應用率下降。不同定序平台、生物資訊流程和檢體處理方案的調查方法不一致，也阻礙了不同檢測機構之間結果的有效比較。

應用於個人化營養管理

將伴侶動物微生物組診斷與個人化營養相結合，為檢測公司、寵物食品製造商和益生菌補充劑開發商帶來了高成長的商業性機會。微生物組分析有助於推薦客製化飲食和選擇益生菌菌株，從而建立了一個附加價值服務平台，其業務範圍已從定期訂閱診斷銷售擴展到基於訂閱的營養計劃。與專有營養平台相結合的直接面對消費者 (DTC) 的檢測套組，可透過推薦和配送個人化補充劑和食品來產生持續收入。微生物組診斷公司與高階寵物食品製造商之間的夥伴關係模式，能夠實現聯合品牌的營養最佳化服務。

由於解釋的複雜性而產生的限制

微生物組數據的解讀本身就十分複雜，包括個體間的高度差異性、特異性部位的微生物群落以及受飲食和環境影響而發生的動態組成變化，這使得將定序結果轉化為臨床可操作的建議面臨巨大挑戰。面向消費者的微生物組報告可能過度簡化複雜的微生物生態系統，導致誤導性的健康聲明，並可能引發不當的自我治療或飲食干預。獸醫可能會對那些報告結果超出既定臨床標準範圍的面向消費者的微生物組診斷平台保持警惕。缺乏充分臨床檢驗的、暗示診斷或預後價值的微生物組檢測，會為檢測公司帶來監管和法律風險。

新型冠狀病毒（COVID-19）的影響：

新冠疫情導致檢查室運作受限和定序供應定序中斷，進而影響了伴侶動物的微生物組診斷，造成檢體處理進度延遲。另一方面，疫情也提升了消費者對腸道健康科學的興趣，該科學既適用於人類也適用於寵物，並提高了大眾對微生物組診斷的認知。疫情封鎖期間寵物飼養量的增加擴大了未來的潛在市場。疫情後，飼主對預防醫學和個人化獸醫護理投入的增加，持續推動了對伴侶動物微生物組檢測及相關營養最佳化服務的需求成長。

在預測期內，檢測套組細分市場預計將佔據最大的市場佔有率。

由於其便利性、易用性以及寵物飼主和獸醫專業人士日益成長的接受度，預計在預測期內，檢測套組細分市場將佔據最大的市場佔有率。這些試劑盒能夠有效率地採集和提交生物樣本進行微生物組分析，從而支持常規健康評估和預防保健工作。人們對微生物組在寵物健康中作用的認知不斷提高，以及對家用診斷解決方案需求的不斷成長，正在推動市場滲透。持續的產品創新和不斷擴大的分銷網路進一步鞏固了該細分市場的領先地位。

預計在預測期內，鳥槍法元基因組定序片段將呈現最高的複合年成長率。

在預測期內，由於鳥槍法元基因組定序定序無需預先選擇目標即可提供微生物群落的全面分析，因此預計該技術將呈現最高的成長速度。這項技術能夠詳細鑑定細菌、病毒、真菌和其他微生物，從而支持先進的診斷和個人化的寵物醫療保健。對精準獸醫學日益成長的需求、對寵物腸道健康研究的不斷深入以及次世代定序平台的進步，都進一步加速了這項技術的應用。其卓越的分析能力不斷拓展其在基於微生物組的疾病評估和健康監測方面的應用範圍。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其先進的獸醫診斷基礎設施、較高的寵物飼養率以及消費者和專業人士對動物健康微生物組科學的高度認知。美國擁有大多數商業性寵物微生物組檢測公司，包括AnimalBiome，並且還有許多領先的研究機構積極推廣寵物微生物組參考資料資料庫計畫。完善的獸醫診斷檢查室網路為微生物組檢測服務提供了專業的管道。消費者科學素養的提高以及寵物保健支出增加的趨勢正在推動直接面對消費者（DTC）的微生物組檢測的普及。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於日本、韓國、中國和澳大利亞寵物飼養量的快速成長、獸醫診斷領域投資的增加以及人們對腸道微生物組科學在寵物健康管理中作用的認知不斷提高。中國和韓國的本土生物技術公司正在開發具有成本競爭力的微生物組檢測平台，以面向國內和區域市場銷售。日本和澳洲的學術研究機構正在積極推進伴侶動物微生物組的研究項目，產生參考數據以支持臨床檢測的開發。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球寵物微生物組診斷市場：依產品分類

  • 檢測套組
  • 裝置
  • 軟體和服務

第6章：全球寵物微生物組診斷市場：依樣本類型分類

  • 糞便樣本
  • 唾液樣本
  • 皮膚拭子檢體
  • 耳拭子檢體

第7章：全球寵物微生物組診斷市場：依動物類型分類

  • 狗
  • 貓
  • 馬
  • 其他動物類型

第8章：全球寵物微生物組診斷市場：依技術分類

  • 16S rRNA定序
  • 鳥槍法元基因組定序
  • 代謝體學
  • qPCR
  • 宏轉錄組學

第9章：全球寵物微生物組診斷市場：依應用分類

  • 消化器官系統健康
  • 皮膚科
  • 營養評估
  • 肥胖管理
  • 免疫系統健康
  • 與行為健康的相關性

第10章：全球寵物微生物組診斷市場：依最終用戶分類

  • 獸醫醫院和診所
  • 診斷檢查室
  • 研究機構
  • 寵物飼主
  • 寵物食品和營養補充品公司

第11章 全球寵物微生物組診斷市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • AnimalBiome, Inc.
  • ThorneVet
  • Microbiome Labs
  • IdePet Microbiome Diagnostics Laboratories, Inc.
  • Zoetis Inc.
  • Nestle Purina PetCare Company
  • Mars, Incorporated
  • Hill's Pet Nutrition, Inc.
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Qiagen NV
  • Eurofins Scientific SE
  • Neogen Corporation
  • NomNomNow Inc.
  • Oligo Basics USA LLC
  • Biome9
  • GlycanAge
Product Code: SMRC37233

According to Stratistics MRC, the Global Pet Microbiome Diagnostics Market is accounted for $0.5 billion in 2026 and is expected to reach $1.6 billion by 2034 growing at a CAGR of 15.6% during the forecast period. Pet Microbiome Diagnostics refers to the analysis and assessment of microbial communities residing in the digestive system, skin, oral cavity, and other biological environments of companion animals using advanced genomic and molecular diagnostic technologies. These diagnostics evaluate the composition, diversity, and functional activity of beneficial and harmful microorganisms to identify imbalances associated with health conditions. Pet microbiome diagnostics support disease detection, nutritional optimization, preventive healthcare, personalized treatment planning, and overall wellness management in pets.

Market Dynamics:

Driver:

Gut health science advances

Rapid expansion of the scientific evidence base connecting companion animal gut microbiome composition to systemic health outcomes across gastrointestinal, immune, dermatological, and behavioral domains is creating growing clinical and consumer demand for diagnostic characterization. Peer-reviewed research demonstrating correlations between specific microbial signatures and conditions including inflammatory bowel disease, food sensitivity, and atopic dermatitis is strengthening veterinary confidence in microbiome diagnostic utility. Probiotic and prebiotic product manufacturers are commissioning microbiome diagnostic testing to validate product efficacy claims and support personalized recommendation platforms.

Restraint:

Lack of veterinary reference standards

The absence of validated reference ranges for healthy companion animal microbiome composition across breeds, ages, and geographic regions significantly limits clinical interpretability of microbiome diagnostic results. Without standardized normative databases, veterinarians cannot reliably distinguish pathological dysbiosis from normal microbial variation, reducing diagnostic confidence and clinical adoption rates. Methodological inconsistencies between sequencing platforms, bioinformatics pipelines, and sample handling protocols prevent meaningful result comparison across testing providers.

Opportunity:

Personalized nutrition applications

The convergence of companion animal microbiome diagnostics with personalized nutrition represents a high-growth commercial opportunity for testing companies, pet food manufacturers, and probiotic supplement developers. Microbiome profiles that inform customized dietary recommendations and probiotic strain selection create value-added service platforms that extend beyond one-time diagnostic sales into subscription nutrition programs. Direct-to-consumer testing kits linked to proprietary nutrition platforms capture recurring revenue through personalized supplement and food recommendation fulfillment. Partnership models between microbiome diagnostic companies and premium pet food manufacturers enable co-branded nutrition optimization services.

Threat:

Interpretation complexity limitations

The inherent complexity of microbiome data interpretation, including high inter-individual variability, site-specific microbial communities, and dynamic compositional responses to diet and environment, poses significant challenges for translating sequencing results into clinically actionable recommendations. Consumer-facing microbiome reports risk oversimplifying complex microbial ecology into misleading health narratives, potentially prompting inappropriate self-treatment or dietary interventions. Veterinarians may distrust consumer microbiome diagnostic platforms that report outside established clinical standards. The regulatory risk of microbiome tests that imply diagnostic or prognostic claims without adequate clinical validation creates legal exposure for testing companies.

Covid-19 Impact:

The COVID-19 pandemic disrupted companion animal microbiome diagnostics through laboratory operational restrictions and sequencing supply chain interruptions that delayed sample processing timelines. The pandemic concurrently elevated consumer interest in gut health science applied to both human and pet contexts, broadening public awareness of microbiome diagnostics. Accelerated pet adoption during lockdowns expanded the future addressable market. Post-pandemic, increased owner investment in preventive and personalized veterinary care has sustained demand momentum for companion animal microbiome testing and related nutritional optimization services.

The testing kits segment is expected to be the largest during the forecast period

The testing kits segment is expected to account for the largest market share during the forecast period, due to their convenience, accessibility, and growing adoption among pet owners and veterinary professionals. These kits enable efficient collection and submission of biological samples for microbiome analysis, supporting routine health assessments and preventive care initiatives. Rising awareness regarding the role of the microbiome in pet health, coupled with increasing demand for at-home diagnostic solutions, is strengthening market penetration. Continuous product innovation and expanding distribution networks further contribute to the segment's dominant position.

The shotgun metagenomic sequencing segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the shotgun metagenomic sequencing segment is predicted to witness the highest growth rate, driven by its ability to provide comprehensive profiling of microbial communities without requiring prior target selection. This technology enables detailed identification of bacteria, viruses, fungi, and other microorganisms, supporting advanced diagnostics and personalized pet healthcare. Growing demand for precision veterinary medicine, increasing research on pet gut health, and advancements in next-generation sequencing platforms are further accelerating adoption. Its superior analytical capabilities continue to expand applications across microbiome-based disease assessment and wellness monitoring.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to its advanced veterinary diagnostics infrastructure, high companion animal ownership rates, and strong consumer and professional awareness of microbiome science in animal health contexts. The United States hosts the majority of commercial companion animal microbiome testing companies, including AnimalBiome, and leading research institutions with active companion animal microbiome reference database programs. Established veterinary diagnostic laboratory networks provide professional distribution channels for microbiome testing services. Consumer science literacy and premium pet health spending patterns support direct-to-consumer microbiome testing adoption.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly expanding companion animal ownership, increasing veterinary diagnostic investment, and growing awareness of gut microbiome science in pet health management across Japan, South Korea, China, and Australia. Local biotechnology companies in China and South Korea are developing cost-competitive companion animal microbiome testing platforms for domestic and regional distribution. Academic research institutions in Japan and Australia maintain active companion animal microbiome study programs, generating reference data that supports clinical test development.

Key players in the market

Some of the key players in Pet Microbiome Diagnostics Market include AnimalBiome, Inc., ThorneVet, Microbiome Labs, IDEXX Laboratories, Inc., Zoetis Inc., Nestle Purina PetCare Company, Mars, Incorporated, Hill's Pet Nutrition, Inc., Thermo Fisher Scientific Inc., Illumina, Inc., Qiagen N.V., Eurofins Scientific SE, Neogen Corporation, NomNomNow Inc., Oligo Basics USA LLC, Biome9 and GlycanAge.

Key Developments:

In May 2026, AnimalBiome, Inc. launched an expanded canine and feline gut microbiome test panel incorporating shotgun metagenomic sequencing, providing breed-adjusted microbial diversity scores and personalized probiotic strain recommendations through an updated clinical reporting platform.

In April 2026, NomNomNow Inc. introduced a subscription-based microbiome monitoring program pairing quarterly fecal microbiome sequencing with dynamically adjusted fresh pet food formulations, targeting dogs with chronic gastrointestinal and dermatological conditions.

In March 2026, Eurofins Scientific SE expanded its veterinary diagnostic laboratory microbiome testing services to include equine gut microbiome profiling across seven European markets, supporting performance nutrition optimization programs for competitive sport horses.

Products Covered:

  • Testing Kits
  • Instruments
  • Software and Services

Sample Types Covered:

  • Fecal Samples
  • Saliva Samples
  • Skin Swab Samples
  • Ear Swab Samples

Animal Types Covered:

  • Dogs
  • Cats
  • Horses
  • Other Companion Animals

Technologies Covered:

  • 16S rRNA Sequencing
  • Shotgun Metagenomic Sequencing
  • Metabolomics
  • qPCR
  • Metatranscriptomics

Applications Covered:

  • Gastrointestinal Health
  • Dermatology
  • Nutritional Assessment
  • Obesity Management
  • Immune System Health
  • Behavioral Health Correlation

End Users Covered:

  • Veterinary Hospitals and Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Pet Owners
  • Pet Food and Supplement Companies

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Pet Microbiome Diagnostics Market, By Product

  • 5.1 Testing Kits
  • 5.2 Instruments
  • 5.3 Software and Services

6 Global Pet Microbiome Diagnostics Market, By Sample Type

  • 6.1 Fecal Samples
  • 6.2 Saliva Samples
  • 6.3 Skin Swab Samples
  • 6.4 Ear Swab Samples

7 Global Pet Microbiome Diagnostics Market, By Animal Type

  • 7.1 Dogs
  • 7.2 Cats
  • 7.3 Horses
  • 7.4 Other Animal Types

8 Global Pet Microbiome Diagnostics Market, By Technology

  • 8.1 16S rRNA Sequencing
  • 8.2 Shotgun Metagenomic Sequencing
  • 8.3 Metabolomics
  • 8.4 qPCR
  • 8.5 Metatranscriptomics

9 Global Pet Microbiome Diagnostics Market, By Application

  • 9.1 Gastrointestinal Health
  • 9.2 Dermatology
  • 9.3 Nutritional Assessment
  • 9.4 Obesity Management
  • 9.5 Immune System Health
  • 9.6 Behavioral Health Correlation

10 Global Pet Microbiome Diagnostics Market, By End User

  • 10.1 Veterinary Hospitals and Clinics
  • 10.2 Diagnostic Laboratories
  • 10.3 Research Institutes
  • 10.4 Pet Owners
  • 10.5 Pet Food and Supplement Companies

11 Global Pet Microbiome Diagnostics Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.11 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.11 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 AnimalBiome, Inc.
  • 14.2 ThorneVet
  • 14.3 Microbiome Labs
  • 14.4 IdePet Microbiome Diagnostics Laboratories, Inc.
  • 14.5 Zoetis Inc.
  • 14.6 Nestle Purina PetCare Company
  • 14.7 Mars, Incorporated
  • 14.8 Hill's Pet Nutrition, Inc.
  • 14.9 Thermo Fisher Scientific Inc.
  • 14.10 Illumina, Inc.
  • 14.11 Qiagen N.V.
  • 14.12 Eurofins Scientific SE
  • 14.14 Neogen Corporation
  • 14.14 NomNomNow Inc.
  • 14.15 Oligo Basics USA LLC
  • 14.16 Biome9
  • 14.17 GlycanAge

List of Tables

  • Table 1 Global Pet Microbiome Diagnostics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Pet Microbiome Diagnostics Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Pet Microbiome Diagnostics Market Outlook, By Testing Kits (2023-2034) ($MN)
  • Table 4 Global Pet Microbiome Diagnostics Market Outlook, By Instruments (2023-2034) ($MN)
  • Table 5 Global Pet Microbiome Diagnostics Market Outlook, By Software and Services (2023-2034) ($MN)
  • Table 6 Global Pet Microbiome Diagnostics Market Outlook, By Sample Type (2023-2034) ($MN)
  • Table 7 Global Pet Microbiome Diagnostics Market Outlook, By Fecal Samples (2023-2034) ($MN)
  • Table 8 Global Pet Microbiome Diagnostics Market Outlook, By Saliva Samples (2023-2034) ($MN)
  • Table 9 Global Pet Microbiome Diagnostics Market Outlook, By Skin Swab Samples (2023-2034) ($MN)
  • Table 10 Global Pet Microbiome Diagnostics Market Outlook, By Ear Swab Samples (2023-2034) ($MN)
  • Table 11 Global Pet Microbiome Diagnostics Market Outlook, By Animal Type (2023-2034) ($MN)
  • Table 12 Global Pet Microbiome Diagnostics Market Outlook, By Dogs (2023-2034) ($MN)
  • Table 13 Global Pet Microbiome Diagnostics Market Outlook, By Cats (2023-2034) ($MN)
  • Table 14 Global Pet Microbiome Diagnostics Market Outlook, By Horses (2023-2034) ($MN)
  • Table 15 Global Pet Microbiome Diagnostics Market Outlook, By Other Animal Types (2023-2034) ($MN)
  • Table 16 Global Pet Microbiome Diagnostics Market Outlook, By Technology (2023-2034) ($MN)
  • Table 17 Global Pet Microbiome Diagnostics Market Outlook, By 16S rRNA Sequencing (2023-2034) ($MN)
  • Table 18 Global Pet Microbiome Diagnostics Market Outlook, By Shotgun Metagenomic Sequencing (2023-2034) ($MN)
  • Table 19 Global Pet Microbiome Diagnostics Market Outlook, By Metabolomics (2023-2034) ($MN)
  • Table 20 Global Pet Microbiome Diagnostics Market Outlook, By qPCR (2023-2034) ($MN)
  • Table 21 Global Pet Microbiome Diagnostics Market Outlook, By Metatranscriptomics (2023-2034) ($MN)
  • Table 22 Global Pet Microbiome Diagnostics Market Outlook, By Application (2023-2034) ($MN)
  • Table 23 Global Pet Microbiome Diagnostics Market Outlook, By Gastrointestinal Health (2023-2034) ($MN)
  • Table 24 Global Pet Microbiome Diagnostics Market Outlook, By Dermatology (2023-2034) ($MN)
  • Table 25 Global Pet Microbiome Diagnostics Market Outlook, By Nutritional Assessment (2023-2034) ($MN)
  • Table 26 Global Pet Microbiome Diagnostics Market Outlook, By Obesity Management (2023-2034) ($MN)
  • Table 27 Global Pet Microbiome Diagnostics Market Outlook, By Immune System Health (2023-2034) ($MN)
  • Table 28 Global Pet Microbiome Diagnostics Market Outlook, By Behavioral Health Correlation (2023-2034) ($MN)
  • Table 29 Global Pet Microbiome Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • Table 30 Global Pet Microbiome Diagnostics Market Outlook, By Veterinary Hospitals and Clinics (2023-2034) ($MN)
  • Table 31 Global Pet Microbiome Diagnostics Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)
  • Table 32 Global Pet Microbiome Diagnostics Market Outlook, By Research Institutes (2023-2034) ($MN)
  • Table 33 Global Pet Microbiome Diagnostics Market Outlook, By Pet Owners (2023-2034) ($MN)
  • Table 34 Global Pet Microbiome Diagnostics Market Outlook, By Pet Food and Supplement Companies (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.